Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Of Arsenic Trioxide In Patients With Refractory Germ Cell Malignancies

NCT00036842 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00036842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Of Arsenic Trioxide In Patients With Refractory Germ Cell Malignancies
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
June 30, 2007
Enrollment
Not reported
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

extragonadal germ cell tumor, testicular germ cell tumor